A239 (Silodosin 8 mg)
Pill with imprint A239 is White, Capsule-shape and has been identified as Silodosin 8 mg. It is supplied by Alembic Pharmaceuticals Inc..
Silodosin is used in the treatment of benign prostatic hyperplasia and belongs to the drug class antiadrenergic agents, peripherally acting. There is no proven risk in humans during pregnancy. Silodosin 8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A239
Silodosin
- Imprint
- A239
- Strength
- 8 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, peripherally acting
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Alembic Pharmaceuticals Inc.
- National Drug Code (NDC)
- 62332-0406
Related Images for "A239"
More about silodosin
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 111 Reviews
- Drug class: antiadrenergic agents, peripherally acting
Consumer resources
- Other brands
- Rapaflo
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.